Sana Biotechnology to webcast presentations at Wells Fargo Healthcare Conference
SANA•Sana Biotechnology to present at four investor conferences in September
- Sana Biotechnology will present at four investor conferences in September 2026, providing a business overview and update.
- First appearance set for Sept. 8, 2026 at the 2026 Wells Fargo Healthcare Conference.
- Additional presentations scheduled for Sept. 10, 2026 at Citi’s 2026 Biopharma Back-to-School Conference.
- Later sessions slated for Sept. 14-15, 2026 at Morgan Stanley’s Global Healthcare Conference, then HC Wainwright’s Global Investment Conference.
Related News
Atyr Pharma Provides Update On Timing Of Regulatory Response For Planned Phase 3 Study Of Efzofitimod In Pulmonary Sarcoidosis
ATYR•
Citigroup announces Q3 2026 distribution of R$ 0.39 per unit, payable Sept. 3
C•
